0

Novavax Inc (NVAX) – Financial and Strategic SWOT Analysis Review

Publisher Name :
Date: 15-Mar-2017
No. of pages: 49

Novavax Inc (NVAX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Novavax Inc (Novavax) is a vaccine company that focuses on the discovery, development and commercialization of novel products to prevent a range of infectious diseases. Its product portfolio includes recombinant nanoparticle vaccines and adjuvants. The company develops vaccines using its proprietary recombinant nanoparticle vaccine technology that includes virus-like particle technology (VLPs), and matrix technology. Its product portfolio includes recombinant nanoparticle vaccines and adjuvants for various infectious diseases. Novavax’s clinical product pipeline includes vaccines indicated against respiratory syncytial virus, influenza, Ebola virus, Zika virus and others. The company has a manufacturing facility in Gaithersburg, Maryland. Novavax operates a subsidiary in Sweden (Novavax AB) and is headquartered in Gaithersburg, Maryland, the US.

Novavax Inc Key Recent Developments

Feb 27, 2017: Novavax Reports Fourth Quarter and Year-End 2016 Financial Results
Nov 09, 2016: Novavax Reports Third Quarter 2016 Financial Results
Aug 09, 2016: Novavax Reports Second Quarter 2016 Financial Results
May 12, 2016: Novavax Receives the Tech Council of Maryland’s Chairman’s Award
May 04, 2016: Novavax Reports First Quarter 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of content
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Novavax Inc - Key Facts 6
Novavax Inc - Key Employees 7
Novavax Inc - Key Employee Biographies 8
Novavax Inc - Major Products and Services 9
Novavax Inc - Pharmaceutical Pipeline Products Data 10
Novavax Inc, Pipeline Products by Therapy Area 10
Novavax Inc, Pipeline Products by Development Phase 11
Novavax Inc - History 12
Novavax Inc - Company Statement 15
Novavax Inc - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 16
Section 2 - Company Analysis 17
Novavax Inc - Business Description 17
Novavax Inc - Corporate Strategy 18
Novavax Inc - SWOT Analysis 19
SWOT Analysis - Overview 19
Novavax Inc - Strengths 19
Novavax Inc - Weaknesses 20
Novavax Inc - Opportunities 21
Novavax Inc - Threats 22
Novavax Inc - Key Competitors 23
Section 3 - Company Financial Ratios 24
Financial Ratios - Capital Market Ratios 24
Financial Ratios - Annual Ratios 25
Performance Chart 27
Financial Performance 27
Financial Ratios - Interim Ratios 28
Financial Ratios - Ratio Charts 29
Section 4 - Company's Lifesciences Financial Deals and Alliances 30
Novavax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30
Novavax Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 31
Novavax Inc, Recent Deals Summary 32
Section 5 - Company's Recent Developments 33
Feb 27, 2017: Novavax Reports Fourth Quarter and Year-End 2016 Financial Results 33
Nov 09, 2016: Novavax Reports Third Quarter 2016 Financial Results 34
Aug 09, 2016: Novavax Reports Second Quarter 2016 Financial Results 36
May 04, 2016: Novavax Reports First Quarter 2016 Financial Results 37
Apr 04, 2016: Novavax Announces Iksung Cho named as Vice President 39
Mar 17, 2016: Novavax Announces Management Promotions 40
Mar 17, 2016: Novavax Appoints Bob Darius Senior Vice President, Quality Operations 41
Feb 29, 2016: Novavax Reports Fourth Quarter and Year-End 2015 Financial Results 42
Jan 08, 2016: Novavax Appoints Jeffrey Stoddard, M.D., Vice President, Medical Affairs 44
Section 6 - Appendix 45
Methodology 45
Ratio Definitions 45
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Novavax Inc, Key Facts 6
Novavax Inc, Key Employees 7
Novavax Inc, Key Employee Biographies 8
Novavax Inc, Major Products and Services 9
Novavax Inc, Number of Pipeline Products by Therapy Area 10
Novavax Inc, Number of Pipeline Products by Development Stage 11
Novavax Inc, History 12
Novavax Inc, Other Locations 16
Novavax Inc, Subsidiaries 16
Novavax Inc, Joint Venture 16
Novavax Inc, Key Competitors 23
Novavax Inc, Ratios based on current share price 24
Novavax Inc, Annual Ratios 25
Novavax Inc (Cont...1), Annual Ratios 26
Novavax Inc, Interim Ratios 28
Novavax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30
Novavax Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 31
Novavax Inc, Recent Deals Summary 32
Currency Codes 45
Capital Market Ratios 45
Equity Ratios 46
Profitability Ratios 46
Cost Ratios 47
Liquidity Ratios 47
Leverage Ratios 47
Efficiency Ratios 48

List of Figures
Novavax Inc, Pipeline Products by Therapy Area 10
Novavax Inc, Pipeline Products by Development Phase 11
Novavax Inc, Performance Chart (2012 - 2016) 27
Novavax Inc, Ratio Charts 29
Novavax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30
Novavax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 31

News

  • Understanding the Need For Travel Vaccination
  • If you are getting ready for a particular trip that can see you away from your house for about a month or so, then it is necessary for you to take the help of travel vaccinations. Not ...
  • The Work Of The Ophthalmology Specialist
  • When we consider ophthalmology as a branch of science, it is actually about the treatment as well as getting to diagnose the different kinds of diseases and the disorder that is to ...
  • The Process Of Dental Implants And The Subsequent Recovery
  • In the United States of America, the fear of going to a dentist happens to rank number one on the list of children as well as adults. Most of the people are actually concerned when ...
  • The medication that can help the rural population
  • It is not always that you get to see world class hospitals in the rural areas, be it America or any other country. Hence, it is important that people actually take the help of tele-medication, ...
  • The Future of Telemedicine & Its Use
  • When talking about telemedicine, you do get to realize that it is the healthcare of the future. Most of the people do not realize the implications, and for more so the time, telemedicine ...

Get Updates

Share This Post

Recent Posts

© 2017 RnR Company Profiles. All rights reserved.